|1.||Ding, Wen-Xiao: 1 article (01/2013)|
|2.||Zhang, Xi-Long: 1 article (01/2013)|
|3.||Ding, Ning: 1 article (01/2013)|
|4.||Liu, Jian-Nan: 1 article (01/2013)|
|5.||Huang, Han-Peng: 1 article (01/2013)|
|6.||Lu, Gan: 1 article (01/2013)|
|7.||Zhang, Xiao-Feng: 1 article (01/2013)|
|8.||McLaughlin, Peter: 1 article (06/2011)|
|9.||Wilhelm, M: 1 article (10/2003)|
|10.||Konrad Müller-Hermelink, H: 1 article (10/2003)|
|1.||Non-Hodgkin Lymphoma (Lymphosarcoma)
03/01/1987 - "Despite the moderate to severe myelotoxicity, these results provide evidence that MEPP is an effective regimen for non-Hodgkin's lymphoma resistant to CHOP or CHOP-bleo."
12/11/1994 - "[CHOP-Bleo therapy in high-malignancy non-Hodgkin lymphoma]."
12/01/1988 - "[Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation]."
02/01/1980 - "[Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program]."
02/01/1996 - "The combination of IF radiation and risk-adapted COP/CHOP-Bleo chemotherapy is well-tolerated, produces a very high rate of complete remission, and with a median follow-up of five years, has produced lower rates of relapse and better overall survival than has been reported for IF radiation alone in patients with clinically-staged I-II low-grade lymphoma."
|2.||Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
10/01/1986 - "The CHOP-Bleo regimen is an effective treatment for diffuse large-cell lymphoma, and is moderately well tolerated. "
04/01/1987 - "A ten-year update of CHOP-BLEO in the treatment of diffuse large-cell lymphoma."
10/01/1986 - "A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma."
10/01/1986 - "Diffuse large-cell lymphoma: more CHOP-Bleo is not better."
08/01/1993 - "Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up."
08/01/1992 - "His lymphoma was refractory to CHOP and CHOP-Bleo regimens. "
10/01/1990 - "[CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas]."
01/01/1989 - "Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. "
01/01/1985 - "[Treatment of non-Hodgkin's lymphomas with CHOP-bleo. "
08/31/1984 - "Bone marrow negative patients were given a conventional lymphoma program with CHOP-Bleo and limited RT on bulky mediastinum without CNS prophylaxis. "
|4.||Burkitt Lymphoma (Burkitt's Lymphoma)
03/01/1985 - "Studies conducted at the NCI demonstrated that 47% of all patients with advanced stages of diffuse mixed, large cell, and undifferentiated non-Burkitt's lymphoma could achieve a complete remission documented by reevaluation of all initially involved sites following treatment with either the C-MOPP or BACOP combination chemotherapy regimens. "
06/25/1993 - "Better survival was observed in patients with B-cell type (72%), smaller mass (tumor limited to the unilateral nasal cavity or paranasal sinus) (76%), and patients who were treated with combination chemotherapy (BACOP) followed by RT (100%). "
11/01/1990 - "We assessed the response of various tumors, following each of three consecutive courses of CHOP or CHOP-Bleo therapy in 32 untreated patients with intermediate or high-grade non-Hodgkin's lymphoma (NHL), and also retrospectively compared these results to those for a group in whom complete remission (CR) had been obtained within five courses and a non-CR group. "
01/01/1995 - "Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation."
01/01/1995 - "Impact of radiation dose and tumor size on large cell lymphoma patients in complete response after integrated CHOP-Bleo-radiation treatment protocol."
11/01/1992 - "When we applied this tumor score system to a population of 144 patients uniformly treated with CHOP/Bleo/CMED protocol, we observed that this system can accurately divide the population into two prognostic groups without an intermediate category. "
|8.||Interferon Alfa-2b (Interferon Alfa 2b)
|1.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|5.||Stem Cell Transplantation